Company Profile

Momenta Pharmaceuticals, Inc. is a biotechnology company. The Company is focused on developing generic versions of drugs, biosimilars and therapeutics for oncology and autoimmune disease. The Company has developed generic version of LOVENOX (enoxaparin sodium injection) and COPAXONE (glatiramer acetate injection). GLATOPA 20 milligrams (mg)/ milliliters (mL) is a generic version of once-daily COPAXONE 20 mg/mL indicated for the treatment of patients with relapsing forms of multiple sclerosis, a chronic disease of the central nervous system characterized by inflammation and neurodegeneration. COPAXONE is available in both a once-daily 20 mg/mL formulation and a three-times-weekly 40 mg/mL formulation. The Company's Enoxaparin Sodium Injection is a generic version of LOVENOX indicated for the prevention and treatment of deep vein thrombosis and to support the treatment of acute coronary syndromes. The Company's programs include M254, M281 (Anti-FcRn candidate) and M230.

Employees

Sector

Biotechnology & Medical Research

More about the company

20-10-01	Momenta Pharmaceuticals, Inc. Announces Executive Changes	CI
20-10-01	Momenta Pharmaceuticals, Inc.(NasdaqGS:MNTA) dropped from S&P TMI Index	CI
20-10-01	Momenta Pharmaceuticals, Inc.(NasdaqGS:MNTA) dropped from S&P 1000	CI
20-10-01	Momenta Pharmaceuticals, Inc.(NasdaqGS:MNTA) dropped from S&P Global BMI Index	CI
20-10-01	Momenta Pharmaceuticals, Inc.(NasdaqGS:MNTA) dropped from S&P Biotechnology Select Industry Index	CI
20-10-01	Momenta Pharmaceuticals, Inc.(NasdaqGS:MNTA) dropped from S&P 600 Health Care	CI
20-10-01	Momenta Pharmaceuticals, Inc.(NasdaqGS:MNTA) dropped from S&P Composite 1500	CI
20-10-01	Momenta Pharmaceuticals, Inc.(NasdaqGS:MNTA) dropped from S&P 600	CI
20-10-01	Momenta Pharmaceuticals, Inc.(NasdaqGM:MNTA) dropped from Russell Small Cap Comp Value Index	CI
20-10-01	Momenta Pharmaceuticals, Inc.(NasdaqGM:MNTA) dropped from Russell 2000 Value Index	CI
20-10-01	Momenta Pharmaceuticals, Inc.(NasdaqGM:MNTA) dropped from Russell 2500 Value Index	CI
20-10-01	Momenta Pharmaceuticals, Inc.(NasdaqGM:MNTA) dropped from Russell 3000 Value Index	CI
20-10-01	Momenta Pharmaceuticals, Inc.(NasdaqGM:MNTA) dropped from Russell Small Cap Comp Growth Index	CI

20-10-05	Johnson & Johnson : Completes Acquisition of Momenta Pharmaceuticals, Inc.; Acquisition broadens Janssen's leadership in autoimmune diseases and provides a major catalyst for sustained growth	AQ
20-10-02	Johnson & Johnson : Completes Acquisition of Momenta Pharmaceuticals, Inc.	AQ
20-10-02	Momenta Pharmaceuticals : Announces Completion of Proposed Sale to Johnson & Johnson	AQ
20-10-01	MOMENTA PHARMACEUTICALS INC : Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits (form 8-K)	AQ
20-10-01	Momenta Pharmaceuticals : Announces Completion of Proposed Sale to Johnson & Johnson	AQ

20-08-20	Wall Street : clôture dans le rouge après les minutes du FOMC
20-08-19	Apple : Wall Street finit en baisse, la Fed reste inquiète pour l'économie
20-08-19	Point marchés-Wall Street finit en baisse, la Fed reste inquiète pour l'économie
20-08-19	VALNEVA :, plus forte hausse du SRD à la clôture du mercredi 19 août 2020
20-08-19	Borsa Usa, S&P 500 ancora ai massimi dopo utili Target e Lowe

Date	Insider	Type	Main position	Quantity	% Market Cap.
10/1/20	Bruce Downey	Issuer sale	Chairman	211,656	0.1779%
10/1/20	Donna Grogan	Issuer sale	Director	75,000	0.0630%
10/1/20	Jane Barlow	Issuer sale	Director	75,000	0.0630%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
MOMENTA PHARMACEUTICALS, INC.	-0.02%	+0.17%	-	-	6.25B
ARGENX SE	+0.88%	+0.08%	+54.51%	+58.77%	53.79B
WUXI APPTEC CO., LTD.	+1.80%	+5.16%	+53.09%	+86.95%	54.69B
INSMED INCORPORATED	+2.36%	-1.74%	+5.26%	+413.24%	23.2B
BIONTECH SE	-10.90%	+2.30%	-15.09%	-14.84%	23.31B
WUXI BIOLOGICS (CAYMAN) INC.	+1.46%	+4.02%	+35.97%	-4.03%	20.03B
GENMAB A/S	+0.30%	-0.40%	+33.13%	-33.46%	17.31B
PHARMAESSENTIA CORPORATION	0.00%	-6.00%	+163.95%	+284.69%	14.99B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	+1.49%	+1.49%	+31.63%	+654.98%	15.36B
EXELIXIS, INC.	+1.79%	+1.16%	+27.46%	+186.52%	13.96B
Average	+0.89%	-2.84%	+43.32%	+181.42%	26.29B
Weighted average by Cap.	+1.06%	-2.45%	+43.22%	+141.28%

Momenta Pharmaceuticals, Inc. Stock

Stocks

MNTA

US60877T1007

Biotechnology & Medical Research

Latest news : Momenta Pharmaceuticals, Inc.

Press Releases: Momenta Pharmaceuticals, Inc.

News in other languages: Momenta Pharmaceuticals, Inc.

Quotes and Performance

Latest insider transactions

Bio Therapeutic Drugs

Company Profile